Humacyte Inc [NASDAQ: HUMA] loss -13.69% on the last trading session, reaching $1.45 price per share at the time.
If compared to the average trading volume of 3.46M shares, HUMA reached a trading volume of 5508375 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here is what top equities market gurus are saying about Humacyte Inc [HUMA]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for HUMA shares is $11.71 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on HUMA stock is a recommendation set at 1.29. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
H.C. Wainwright have made an estimate for Humacyte Inc shares, keeping their opinion on the stock as Buy, with their previous recommendation back on December 20, 2024. While these analysts kept the previous recommendation, H.C. Wainwright raised their target price to Buy. The new note on the price target was released on December 11, 2023, representing the official price target for Humacyte Inc stock. Previously, the target price had yet another raise from $2.75 to $3.50, while Piper Sandler kept a Neutral rating on HUMA stock.
Trading performance analysis for HUMA stock
Humacyte Inc [HUMA] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -5.23. With this latest performance, HUMA shares dropped by -54.40% in over the last four-week period, additionally sinking by -75.04% over the last 6 months – not to mention a drop of -53.53% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for HUMA stock in for the last two-week period is set at 34.20, with the RSI for the last a single of trading hit 36.37, and the three-weeks RSI is set at 33.84 for Humacyte Inc [HUMA]. The present Moving Average for the last 50 days of trading for this stock 2.7186, while it was recorded at 1.5420 for the last single week of trading, and 4.8691 for the last 200 days.
Humacyte Inc [HUMA]: A deeper dive into fundamental analysis
Humacyte Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 2.40 and a Current Ratio set at 2.40.
An analysis of Institutional ownership at Humacyte Inc [HUMA]
There are presently around $27.48%, or 34.90%% of HUMA stock, in the hands of institutional investors. The top three institutional holders of HUMA stocks are: BLACKROCK INC. with ownership of 7.14 million shares, which is approximately 5.9912%. VANGUARD GROUP INC, holding 4.73 million shares of the stock with an approximate value of $$22.7 million in HUMA stocks shares; and VANGUARD GROUP INC, currently with $$13.77 million in HUMA stock with ownership which is approximately 2.4071%.
